The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer

Biochemical Pharmacology

Volumn 85, Issue 5, 2013, Pages 597-606

  Wang, Xingya ^a   Baek, Seung Joon ^b   Eling, Thomas E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Cancer; GDF15; NAG 1; Tumor suppressor

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH DIFFERENTIATION FACTOR 15; NAG 1 PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BRAIN CANCER; BRAIN TUMOR; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; MELANOMA; NONHUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; STOMACH CANCER; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; NEOPLASMS;

EID: 84873413504     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.11.025     Document Type: Review

References (95)

1. S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities Mol Pharmacol 59 2001 901 908
2. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, and X.Y. He MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci USA 94 1997 11514 11519
3. P.X. Li, J. Wong, A. Ayed, D. Ngo, A.M. Brade, and C. Arrowsmith Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J Biol Chem 275 2000 20127 20135
4. V.M. Paralkar, A.L. Vail, W.A. Grasser, T.A. Brown, H. Xu, and S. Vukicevic Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family J Biol Chem 273 1998 13760 13767
5. M. Bottner, M. Laaff, B. Schechinger, G. Rappold, K. Unsicker, and C. Suter-Crazzolara Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1) Gene 237 1999 105 111
6. R. Hromas, M. Hufford, J. Sutton, D. Xu, Y. Li, and L. Lu PLAB, a novel placental bone morphogenetic protein Biochim Biophys ACTA 1354 1997 40 44
7. M. Mimeault, and S.K. Batra Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer J Cell Physiol 224 2010 626 635
8. L.N. Lawton, M.F. Bonaldo, P.C. Jelenc, L. Qiu, S.A. Baumes, and R.A. Marcelino Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta Gene 203 1997 17 26
9. A.R. Bauskin, H.-P. Zhang, W.D. Fairlie, X.Y. He, P.K. Russell, and A.G. Moore The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-{beta} superfamily member, acts as a quality control determinant for correctly folded MIC-1 EMBO J 19 2000 2212 2220
10. A.R. Bauskin, D.A. Brown, S. Junankar, K.K. Rasiah, S. Eggleton, and M. Hunter The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome Cancer Res 65 2005 2330 2336
11. X. Wang, K. Chrysovergis, R.J. Bienstock, M. Shim, and T.E. Eling The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo Prostate 72 2012 677 689
12. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc Natl Acad Sci USA 97 2000 109 114
13. Y.J. Park, H. Lee, and J.H. Lee Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells BMB Rep 43 2010 91 96
14. K.K. Kim, J.J. Lee, Y. Yang, K.H. You, and J.H. Lee Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells Carcinogenesis 29 2008 704 712
15. E.C. Hsiao, L.G. Koniaris, T. Zimmers-Koniaris, S.M. Sebald, T.V. Huynh, and S.J. Lee Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 2000 3742 3751
16. S.J. Baek, J.M. Horowitz, and T.E. Eling Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3 J Biol Chem 276 2001 33384 33392
17. K. Yamaguchi, N.C. Whitlock, J.L. Liggett, A.M. Legendre, M.M. Fry, and S.J. Baek Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1) Vet J 175 2008 89 95
18. S.J. Baek, L.C. Wilson, C.H. Lee, and T.E. Eling Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene J Pharmacol Exp Ther 301 2002 1126 1131
19. S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 432
20. L.C. Wilson, S.J. Baek, A. Call, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells Int J Cancer 105 2003 747 753
21. F.G. Bottone Jr., S.J. Baek, J.B. Nixon, and T.E. Eling Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells J Nutr 132 2002 773 778
22. S.H. Lee, K. Yamaguchi, J.S. Kim, T.E. Eling, S. Safe, and Y. Park Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner Carcinogenesis 27 2006 972 981
23. S.J. Baek, J.S. Kim, F.R. Jackson, T.E. Eling, M.F. McEntee, and S.H. Lee Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells Carcinogenesis 25 2004 2425 2432
24. Kang SU, Lee B-S, Lee S-H, Baek SJ, Shin YS, Kim C-H. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J Nutr Biochem; in press.
25. S.H. Lee, J.S. Kim, K. Yamaguchi, T.E. Eling, and S.J. Baek Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner Biochem Biophys Res Commun 328 2005 63 69
26. S.H. Lee, R.L. Richardson, R.H. Dashwood, and S.J. Baek Capsaicin represses transcriptional activity of beta-catenin in human colorectal cancer cells J Nutr Biochem 23 2012 646 655
27. T. Nualsanit, P. Rojanapanthu, W. Gritsanapan, S.H. Lee, D. Lawson, and S.J. Baek Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells J Nutr Biochem 23 2012 915 923
28. S.J. Baek, L.C. Wilson, L.C. Hsi, and T.E. Eling Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity J Biol Chem 278 2003 5845 5853
29. K. Yamaguchi, S.H. Lee, T.E. Eling, and S.J. Baek A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells Mol Cancer Ther 5 2006 1352 1361
30. S. Chintharlapalli, S. Papineni, S.J. Baek, S. Liu, and S. Safe 1,1-Bis(3′-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1 Mol Pharmacol 68 2005 1782 1792
31. S.C. Chiu, M.J. Wang, H.H. Yang, S.P. Chen, S.Y. Huang, and Y.L. Chen Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells BMC Cancer 11 2011 146
32. D. Newman, M. Sakaue, J.S. Koo, K.S. Kim, S.J. Baek, and T. Eling Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids Mol Pharmacol 63 2003 557 564
33. K. Vanderlaag, Y. Su, A.E. Frankel, H. Grage, R. Smith 3rd, and S. Khan 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways Breast Cancer Res Treat 109 2008 273 283
34. S.J. Baek, J.S. Kim, S.M. Moore, S.H. Lee, J. Martinez, and T.E. Eling Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein Mol Pharmacol 67 2005 356 364
35. J.M. Martinez, S.J. Baek, D.M. Mays, P.K. Tithof, T.E. Eling, and N.J. Walker EGR1 is a novel target for AhR agonists in human lung epithelial cells Toxicol Sci 82 2004 429 435
36. S.H. Lee, C. Krisanapun, and S.J. Baek NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3 Carcinogenesis 31 2010 719 728
37. H. Yoshioka, H. Kamitani, T. Watanabe, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A J Biol Chem 283 2008 33129 33137
38. M. Kadowaki, H. Yoshioka, H. Kamitani, T. Watanabe, P.A. Wade, and T.E. Eling DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines Int J Cancer 130 2012 267 277
39. J.M. Martinez, T. Sali, R. Okazaki, C. Anna, M. Hollingshead, and C. Hose Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth J Pharmacol Exp Ther 318 2006 899 906
40. J.R. Lambert, J.A. Kelly, M. Shim, W.E. Huffer, S.K. Nordeen, and S.J. Baek Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth J Cell Physiol 208 2006 566 574
41. M. Albertoni, P.H. Shaw, M. Nozaki, S. Godard, M. Tenan, and M.F. Hamou Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 Oncogene 21 2002 4212 4219
42. T.E. Eling, S.J. Baek, M. Shim, and C.H. Lee NSAID activated gene (NAG-1), a modulator of tumorigenesis J Biochem Mol Biol 39 2006 649 655
43. S.J. Baek, R. Okazaki, S.H. Lee, J. Martinez, J.S. Kim, and K. Yamaguchi Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia Gastroenterology 131 2006 1553 1560
44. M. Cekanova, S.H. Lee, R.L. Donnell, M. Sukhthankar, T.E. Eling, and S.M. Fischer Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice Cancer Prev Res (Phila) 2 2009 450 458
45. Y. Husaini, M.R. Qiu, G.P. Lockwood, X.W. Luo, P. Shang, and T. Kuffner Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice PLoS ONE 7 2012 e43833
46. T.A. Zimmers, J.C. Gutierrez, and L.G. Koniaris Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+mouse model of intestinal cancer J Cancer Res Clin Oncol 136 2010 571 576
47. G.M. Boyle, J. Pedley, A.C. Martyn, K.J. Banducci, G.M. Strutton, and D.A. Brown Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity J Invest Dermatol 129 2009 383 391
48. S. Senapati, S. Rachagani, K. Chaudhary, S.L. Johansson, R.K. Singh, and S.K. Batra Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway Oncogene 29 2010 1293 1302
49. D. Karan, S.J. Chen, S.L. Johansson, A.P. Singh, V.M. Paralkar, and M.F. Lin Dysregulated expression of MIC-1/PDF in human prostate tumor cells Biochem Biophys Res Commun 305 2003 598 604
50. D.H. Lee, Y. Yang, S.J. Lee, K.Y. Kim, T.H. Koo, and S.M. Shin Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system Cancer Res 63 2003 4648 4655
51. D.A. Brown, R.L. Ward, P. Buckhaults, T. Liu, K.E. Romans, and N.J. Hawkins MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma Clin Cancer Res 9 2003 2642 2650
52. D.A. Brown, K.W. Hance, C.J. Rogers, L.B. Sansbury, P.S. Albert, and G. Murphy Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev 21 2012 337 346
53. Ko JK, Auyeung KK. Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation. Curr Pharm Des; in press.
54. S.Y. Shin, J.H. Kim, J.H. Lee, Y. Lim, and Y.H. Lee 2′- Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells Mol Nutr Food Res 56 2012 761 774
55. Y. Zhong, C. Krisanapun, S.H. Lee, T. Nualsanit, C. Sams, and P. Peungvicha Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53 Eur J Cancer 46 2010 3365 3374
56. D. Thapa, D. Babu, M.A. Park, M.K. Kwak, Y.R. Lee, and J.M. Kim Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells Biochem Pharmacol 80 2010 62 71
57. S.H. Park, H.J. Choi, H. Yang, K.H. Do, J. Kim, and H.H. Kim Two in-and-out modulation strategies for endoplasmic reticulum stress-linked gene expression of pro-apoptotic macrophage-inhibitory cytokine 1 J Biol Chem 287 2012 19841 19855
58. L.A. Feagins, R.F. Souza, and S.J. Spechler Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer Nat Rev Gastroenterol Hepatol 6 2009 297 305
59. H. Kadara, C.P. Schroeder, D. Lotan, C. Pisano, and R. Lotan Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis Cancer Biol Ther 5 2006 518 522
60. Y.L. Chen, P.C. Lin, S.P. Chen, C.C. Lin, N.M. Tsai, and Y.L. Cheng Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells J Pharmacol Exp Ther 323 2007 746 756
61. C.H. Kim, M.Y. Kim, J.Y. Moon, J.W. Hwang, S.Y. Lee, and Y.M. Joo Implication of NAG-1 in synergistic induction of apoptosis by combined treatment of sodium salicylate and PI3K/MEK1/2 inhibitors in A549 human lung adenocarcinoma cells Biochem Pharmacol 75 2008 1751 1760
62. R.J. Mason, M. Kalina, L.D. Nielsen, A.M. Malkinson, and J.M. Shannon Surfactant protein C expression in urethane-induced murine pulmonary tumors Am J Pathol 156 2000 175 182
63. A. Dutt, and K.K. Wong Mouse models of lung cancer Clin Cancer Res 12 2006 4396s 4402s
64. Y.L. Yu, K.J. Su, C.J. Chen, C.W. Wei, C.J. Lin, and G.T. Yiang Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells J Cell Physiol 227 2012 213 222
65. N. Bardeesy, and R.A. DePinho Pancreatic cancer biology and genetics Nat Rev Cancer 2 2002 897 909
66. A.F. Hezel, A.C. Kimmelman, B.Z. Stanger, N. Bardeesy, and R.A. Depinho Genetics and biology of pancreatic ductal adenocarcinoma Genes Dev 20 2006 1218 1249
67. S. Chintharlapalli, S. Papineni, S. Liu, I. Jutooru, G. Chadalapaka, and S.D. Cho 2-Cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells Carcinogenesis 28 2007 2337 2346
68. K.W. Min, X. Zhang, T. Imchen, and S.J. Baek A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4 Toxicol Appl Pharmacol 263 2012 225 232
69. I. Jutooru, G. Chadalapaka, S. Chintharlapalli, S. Papineni, and S. Safe Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative Mol Carcinog 48 2009 692 702
70. M. Youns, T. Efferth, and J.D. Hoheisel Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells Eur J Pharmacol 650 2011 170 177
71. T. Liu, A.R. Bauskin, J. Zaunders, D.A. Brown, S. Pankhurst, and P.J. Russell Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells Cancer Res 63 2003 5034 5040
72. S. Wynne, and D. Djakiew NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway Mol Cancer Res 8 2010 1656 1664
73. S.J. Chen, D. Karan, S.L. Johansson, F.F. Lin, J. Zeckser, and A.P. Singh Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells Prostate 67 2007 557 571
74. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, and A.R. Bauskin Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci U S A 100 2003 3410 3415
75. D.A. Brown, C. Stephan, R.L. Ward, M. Law, M. Hunter, and A.R. Bauskin Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis Clin Cancer Res 12 2006 89 96
76. K.S. Selander, D.A. Brown, G.B. Sequeiros, M. Hunter, R. Desmond, and T. Parpala Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases Cancer Epidemiol Biomarkers Prev 16 2007 532 537
77. J. Koopmann, P. Buckhaults, D.A. Brown, M.L. Zahurak, N. Sato, and N. Fukushima Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers Clin Cancer Res 10 2004 2386 2392
78. D.A. Brown, F. Lindmark, P. Stattin, K. Balter, H.O. Adami, and S.L. Zheng Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer Clin Cancer Res 15 2009 6658 6664
79. W.D. Fairlie, P.K. Russell, W.M. Wu, A.G. Moore, H.P. Zhang, and P.K. Brown Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities Biochemistry 40 2001 65 73
80. F. Lindmark, S.L. Zheng, F. Wiklund, J. Bensen, K.A. Balter, and B. Chang H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer J Natl Cancer Inst 96 2004 1248 1254
81. V.M. Hayes, G. Severi, M.C. Southey, E.J. Padilla, D.R. English, and J.L. Hopper Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival Cancer Epidemiol Biomarkers Prev 15 2006 1223 1225
82. I. Cheng, L.M. Krumroy, S.J. Plummer, G. Casey, and J.S. Witte MIC1 and IL1RN genetic variation and advanced prostate cancer risk Cancer Epidemiol Biomarkers Prev 16 2007 1309 1311
83. K.E. Baek, S.R. Yoon, J.-T. Kim, K.S. Kim, S.H. Kang, and Y. Yang Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers Clin Chim Acta 401 2009 128 133
84. T.J. Jang, H.J. Kang, J.R. Kim, and C.H. Yang Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis Carcinogenesis 25 2004 1853 1858
85. R.P. Pang, J.G. Zhou, Z.R. Zeng, X.Y. Li, W. Chen, and M.H. Chen Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway Cancer Lett 251 2007 268 277
86. R. Wang, Y.J. Ciren, J.L. Yang, B. Zhang, J.P. Chen, and C.W. Tang Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene Sichuan Da Xue Xue Bao Yi Xue Ban 40 2009 1029 1032
87. M.T. Huang, Z.X. Chen, B. Wei, B. Zhang, C.H. Wang, and M.H. Huang Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide Acta Pharmacol Sin 28 2007 1842 1850
88. C. Bosetti, V. Rosato, S. Gallus, J. Cuzick, and C. La Vecchia Aspirin and cancer risk: a quantitative review to 2011 Ann Oncol 23 2012 1403 1415
89. A. Gonzalez-Perez, L.A. Garcia Rodriguez, and R. Lopez-Ridaura Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis BMC Cancer 3 2003 28
90. K.S. Kim, S.J. Baek, G.P. Flake, C.D. Loftin, B.F. Calvo, and T.E. Eling Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 2002 1388 1398
91. X. Wang, P.J. Kingsley, L.J. Marnett, and T.E. Eling The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac Cancer Prev Res (Phila) 4 2011 150 160
92. J.H. Kim, J.H. Chang, K.H. Rhee, J.H. Yoon, S.H. Kwon, and K. Song Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene Int J Cancer 122 2008 1765 1773
93. G. Iguchi, K. Chrysovergis, S.H. Lee, S.J. Baek, R. Langenbach, and T.E. Eling A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2 Cancer Lett 282 2009 152 158
94. J.S. Kim, S.J. Baek, T. Sali, and T.E. Eling The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15 Mol Cancer Ther 4 2005 487 493
95. H.C. Diener Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Int J Stroke 1 2006 4 8